These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3426 related articles for article (PubMed ID: 7332319)

  • 41. Effect of radiographic contrast media on complement components C3 and C4: generation of C3b-like C3 and C4b-like C4.
    von Zabern I; Przyklenk H; Vogt W; Sachsenheimer W
    Int J Immunopharmacol; 1983; 5(6):503-13. PubMed ID: 6607225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Binding of activated C3b component with complement effector].
    Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS
    Bioorg Khim; 1985 Jun; 11(6):762-8. PubMed ID: 3849970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Third component of human complement: C3.
    Berger M
    Methods Enzymol; 1990; 184():619-28. PubMed ID: 2143801
    [No Abstract]   [Full Text] [Related]  

  • 44. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
    Baatrup G; Svehag SE; Jensenius JC
    Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kallikrein Cleaves C3 and Activates Complement.
    Irmscher S; Döring N; Halder LD; Jo EAH; Kopka I; Dunker C; Jacobsen ID; Luo S; Slevogt H; Lorkowski S; Beyersdorf N; Zipfel PF; Skerka C
    J Innate Immun; 2018; 10(2):94-105. PubMed ID: 29237166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of kinetics and target proteins for binding of human complement component C3 to the surface-exposed outer membrane of Chlamydia trachomatis serovar L2.
    Hall RT; Strugnell T; Wu X; Devine DV; Stiver HG
    Infect Immun; 1993 May; 61(5):1829-34. PubMed ID: 8478073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
    J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The structure of complement C3b provides insights into complement activation and regulation.
    Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
    Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradation.
    Seifert PS; Roth I; Zioncheck TF
    Atherosclerosis; 1992 Apr; 93(3):209-16. PubMed ID: 1534227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural insights on complement activation.
    Alcorlo M; López-Perrote A; Delgado S; Yébenes H; Subías M; Rodríguez-Gallego C; Rodríguez de Córdoba S; Llorca O
    FEBS J; 2015 Oct; 282(20):3883-91. PubMed ID: 26250513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. gp72, the 72 kilodalton glycoprotein, is the membrane acceptor site for C3 on Trypanosoma cruzi epimastigotes.
    Joiner K; Hieny S; Kirchhoff LV; Sher A
    J Exp Med; 1985 May; 161(5):1196-212. PubMed ID: 3886827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
    Sturtevant JE; Balber AE
    Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes.
    Edberg JC; Tosic L; Wright EL; Sutherland WM; Taylor RP
    J Immunol; 1988 Dec; 141(12):4258-65. PubMed ID: 3198918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale).
    Belew PW; Rosenberg EW; Jennings BR
    Mycopathologia; 1980 Mar; 70(3):187-91. PubMed ID: 6900183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accelerated nonproteolytic cleavage of C3 in plasma from patients with primary biliary cirrhosis.
    Lindgren S
    J Lab Clin Med; 1989 Dec; 114(6):655-61. PubMed ID: 2531785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation.
    Erdei A; Spaeth E; Alsenz J; Rüde E; Schulz T; Gergely J; Dierich MP
    Mol Immunol; 1984 Dec; 21(12):1215-21. PubMed ID: 6240596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
    Luo S; Dasari P; Reiher N; Hartmann A; Jacksch S; Wende E; Barz D; Niemiec MJ; Jacobsen I; Beyersdorf N; Hünig T; Klos A; Skerka C; Zipfel PF
    Mol Immunol; 2018 Jan; 93():266-277. PubMed ID: 28860090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C3-dependent effector functions of complement.
    Zarantonello A; Revel M; Grunenwald A; Roumenina LT
    Immunol Rev; 2023 Jan; 313(1):120-138. PubMed ID: 36271889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 172.